Skip to main content

Table 1 Major adverse clinical events at 12 months

From: The Proliferation REduction with Vascular ENergy Trial (PREVENT)

  Radiotherapy Control  
Event (n = 80) (n = 25) P value
MACE (death, MI, TLR) 13 (16%) 6 (24%) ns
MACE (death, MI, TVR) 21 (26%) 8 (32%) ns
Death 1 (1%) 0 (0%) ns
MI    
   Total 8 (10%) 1 (4%) ns
   Q-wave 2 (3%) 0 (0%)  
   non-Q-wave 6 (7%) 1 (4%)  
TLR5 (6%) 6 (24%) <0.05  
TVR 17 (21%) 8 (32%) ns
  1. MACE, major adverse clinical events; MI, myocardial infarction; TLR, target lesion revascularization; TVR, target vessel revascularization.